Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Wayne B Harris"'
Autor:
Yuan Liu, Haydn Kissick, Viraj A Master, Mehmet Asim Bilen, Dylan Martini, Lauren Yantorni, Sarah Caulfield, Bassel Nazha, Omer Kucuk, Deepak Ravindranathan, Kenneth Ogan, Jacqueline T Brown, Julie M Shabto, Emilie Elise Hitron, Greta Anne Russler, Shreyas Subhash Joshi, Bradley C Carthon, Wayne B Harris
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background The modified Glasgow Prognostic Score (mGPS) is a composite biomarker that uses albumin and C reactive protein (CRP). There are multiple immune checkpoint inhibitor (ICI)-based combinations approved for metastatic renal cell carcinoma (mRC
Externí odkaz:
https://doaj.org/article/4f2dc748bda445bcbb2fb153c0efb1a8
Autor:
Wayne B Harris, Chao Zhang, Yuan Liu, Dale K Robertson, Mikhail Y Akbashev, Brian M Lingerfelt, Omer Kucuk, Bradley C Carthon, Theresa W Gillespie, Adeboye O Osunkoya, Viraj A Master
Publikováno v:
Tumor Biology, Vol 39 (2017)
The goal of this study was to examine time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma. Retrospective chart reviews were conducted at the Winship Cancer Institute of Emory Unive
Externí odkaz:
https://doaj.org/article/604558ee9cd14030b15ff74d5024d914
Autor:
Caroline G Tai, Timothy V Johnson, Ammara Abbasi, Lindsey Herrell, Wayne B Harris, Omer Kucuk, Daniel J Canter, Kenneth Ogan, John G Pattaras, Peter T Nieh, Viraj A Master
Publikováno v:
Indian Journal of Urology, Vol 30, Iss 1, Pp 33-37 (2014)
Purpose: The modified Glasgow prognostic Score (mGPS) incorporates C-reactive protein and albumin as a clinically useful marker of tumor behavior. The ability of the mGPS to predict metastasis in localized renal cell carcinoma (RCC) remains unknown i
Externí odkaz:
https://doaj.org/article/8d4114a27e7445acb72d08ef57ead841
Autor:
Dylan J. Martini, T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Emilie Elise Hitron, Greta Anne Russler, Lauren Yantorni, Sarah Caulfield, Jacqueline T. Brown, Jamie M. Goldman, Bassel Nazha, Bradley C. Carthon, Wayne B. Harris, Omer Kucuk, Viraj A Master, Mehmet Asim Bilen
Publikováno v:
Journal of immunotherapy and precision oncology. 5(3)
Introduction There are three combination immune checkpoint inhibitor (ICI)–based regimens in the first-line setting for metastatic renal cell carcinoma (mRCC). Currently, there is limited real-world data for clinical outcomes and toxicity in mRCC p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec81d838ccf27e7fad75b3783cf769c7
https://pubmed.ncbi.nlm.nih.gov/36034580
https://pubmed.ncbi.nlm.nih.gov/36034580
Autor:
Dylan J. Martini, T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Benjamin Magod, Jacqueline T. Brown, Lauren Yantorni, Greta Anne Russler, Sarah Caulfield, Jamie M. Goldman, Bassel Nazha, Haydn T. Kissick, Wayne B. Harris, Omer Kucuk, Bradley C. Carthon, Viraj A. Master, Mehmet Asim Bilen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundImmune checkpoint inhibitors (ICI) have revolutionized the treatment of metastatic renal cell carcinoma (mRCC). Biomarkers for mRCC patients treated with ICI are limited, and body composition is underutilized in mRCC. We investigated the as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0457555626313be0af9258ec6712054c
Autor:
T. Anders Olsen, Dylan J. Martini, Subir Goyal, Yuan Liu, Sean T. Evans, Benjamin Magod, Jacqueline T. Brown, Lauren Yantorni, Greta Anne Russler, Sarah Caulfield, Jamie M. Goldman, Wayne B. Harris, Omer Kucuk, Bradley C. Carthon, Viraj A. Master, Bassel Nazha, Mehmet Asim Bilen
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundImmune-checkpoint-inhibitors (ICIs) have become the cornerstone of metastatic renal-cell-carcinoma (mRCC) therapy. However, data are limited regarding clinical outcomes by race. In this study, we compared the real-world outcomes between Afr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0759f5962bb6d9a61da43ce5ffbc58c5
Autor:
Wayne B. Harris
Publikováno v:
Urologic Oncology ISBN: 9783319426037
Urologic Oncology
Urologic Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e9ab6361e89e8c3449b83b25925390f
https://doi.org/10.1007/978-3-319-42623-5_55
https://doi.org/10.1007/978-3-319-42623-5_55
Autor:
Bradley C. Carthon, Mikhail Y. Akbashev, Adeboye O. Osunkoya, Chao Zhang, Wayne B. Harris, Viraj A. Master, Omer Kucuk, Brian M. Lingerfelt, Yuan Liu, Theresa W. Gillespie, Dale Kesley Robertson
Publikováno v:
Tumor Biology, Vol 39 (2017)
The goal of this study was to examine time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma. Retrospective chart reviews were conducted at the Winship Cancer Institute of Emory Unive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08415d456100bf33f0cad2ee2ba3242f
https://doaj.org/article/604558ee9cd14030b15ff74d5024d914
https://doaj.org/article/604558ee9cd14030b15ff74d5024d914
Autor:
Zhiheng Xu, Donald L. Bliwise, Catherine I. Vena, Maria H.L. Ribeiro, Sanjay R. Jain, Kathy P. Parker, Wayne B. Harris, Andre Rogatko, Mary Kay Kohles-Baker
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(15)
Purpose Sleep/wake disturbances are prevalent in patients with advanced cancer, but 24-hour polysomnography (PSG) examinations of these patterns have not been undertaken. The purpose of this study was to describe these sleep/wake patterns using conti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6e75f929a8f8043b5aebb447674c81d
https://pubmed.ncbi.nlm.nih.gov/18487562
https://pubmed.ncbi.nlm.nih.gov/18487562
Publikováno v:
Anticancer research. 27(3B)
The androgen receptor (AR) plays an important role in the development and progression of prostate cancer. Functional AR expression persists in most cases of hormone-refractory prostate cancer and may play a role clinically in the progression from hor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::51a0e20232c2188a2d6f144f510c92d0
https://pubmed.ncbi.nlm.nih.gov/17595765
https://pubmed.ncbi.nlm.nih.gov/17595765